Breanna DiAndreth PhD

A2 Biotherapeutics, Inc.

Appearances

Short Talk: Engineered T Cells Directed at Tumors with Defined Allelic Loss
Date
May 4, 2021
Speaker
Breanna DiAndreth, PhD
A2 Biotherapeutics, Inc.
Synthetic Biology: Industry Perspective
Date
May 4, 2021
Co-Chairs
Breanna DiAndreth, PhD
A2 Biotherapeutics, Inc.
Jose M. Lora, PhD
enGene, Inc

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.

Breanna DiAndreth PhD

A2 Biotherapeutics, Inc.

Appearances

Short Talk: Engineered T Cells Directed at Tumors with Defined Allelic Loss

Speaker

Synthetic Biology: Industry Perspective

Co-Chairs